The University of Colorado Denver | Anschutz Medical Campus (CU Denver/Anschutz) is dedicated to ensuring a safe and secure environment for our faculty, staff, students, and visitors. To assist in achieving that goal, we conduct background investigations for all prospective employees.
CU Denver/Anschutz is committed to recruiting and supporting a diverse student body, faculty and administrative staff. The university strives to promote a culture of inclusiveness, respect, communication and understanding. We encourage applications from women, ethnic minorities, persons with disabilities and all veterans. The University of Colorado is committed to diversity and equality in education and employment.
The Immigration Reform and Control Act requires that verification of employment eligibility be documented for all new employees by the end of the third day of work. Alternative formats of this ad are available upon request for persons with disabilities.
| apply | posted on | investigator | laboratory focus | position description | contact | |
|---|---|---|---|---|---|---|
 |
03/13/2025 | Jason Klein, MD, PhD | Our lab uses single-cell and high-throughput perturbation screens to understand how gene regulation contributes to the development, prognosis, and treatment of cutaneous cancers. We will be at the bridge of genomics and cutaneous oncology. | We are seeking a highly motivated postdoctoral Fellow to join the Klein Lab, part of the Department of Dermatology at the University of Colorado Anschutz Medical Campus. The appointment will be for a two to three-year period. The main emphasis of this position will be working in the research areas of genomics, cancer biology, and patient-derived organoids. Experience in genomics and cancer biology, particularly single-cell sequencing, high-throughput screens, and tissue culture, is desired. Please reach out directly and/or apply through CU Careers. I am a surgeon-scientist and our lab will have unique access to patient samples and rare tumors, as well as clinical insight to cutaneous oncology. | Jason Klein, jason.klein@cuanschutz.edu | |
|
|
01/23/2025 | Nancy F. Krebs | The objective of the Nutrition T32 fellowship is to provide research training to physician scientists, basic researchers, and behavioral scientists who are committed to prevention of disease and health promotion through careers in human nutrition | Areas of interest include obesity and energy balance; behavioral research related to eating & obesity; health promotion & nutrition education; implementation science; molecular, genetic, and environmental basis of insulin resistance and Type 2 diabetes; micronutrient homeostasis and effects of nutrient deficiency states; global nutrition; maternal and fetal nutrient utilization; fetal origins of adult disease, human aging; and the epidemiology of nutrition-related conditions. Faculty expertise ranges from clinical trials, neuroimaging, tissue, cellular and molecular methodologies to intervention development based on behavioral, physical, and social environmental factors across the life course. | NutritionT32@cuanschutz.edu | |
|
|
09/12/2024 | Katharina Hopp, PhD | Dr. Hopp’s laboratory studies the pathomechanisms driving Autosomal Dominant Polycystic Kidney Disease (ADPKD). ADPKD is the most common monogenic renal disease worldwide. | We are interested in studying the role of the microenvironment, specifically immune cells, in ADPKD progression and apply the knowledge gained from the cancer field to PKD to develop novel interventional strategies. Key Responsibilities: • Utilize mouse/rat models for mechanistic research and preclinical intervention studies. • Perform basic cellular/molecular techniques that drive hypothesis-based research • Develop independent projects leading to grants, posters, manuscripts. • Condense, analyze, present, and write-up project results. • Supervise and work alongside graduate students and research technicians within the Hopp lab. | Betsy Pike, Renal Division Human Resources, betsy.pike@cuanschutz.edu | |
|
|
05/06/2024 | Charles Sagerstrom | Transcriptional and epigenetic control of cell fate decisions during embryonic development | During embryogenesis, the developing embryo goes through numerous transitions as new tissues, organs and cell types are formed. Each such transition is driven by a change in gene expression that can go awry and cause birth defects. We are interested in understanding how transcription factors and chromatin regulators drive gene expression programs to support the formation of new cells and tissues, using zebrafish as a model. Our group is looking for postdoctoral fellows to join our work using bioinformatics, imaging and genetic/genomic tools (scRNAseq, scATACseq, CRISPR, transgenesis) to unravel the control of cell fate decisions. Lab website: external link . Recent manuscript: doi.org/10.7554/eLife.87772.. | Charles.sagerstrom@cuanschutz.edu |
